Khalil Barrage - May 26, 2021 Form 4 Insider Report for Protagenic Therapeutics, Inc.\new (PTIX)

Role
Director
Signature
/s/ Alexander Arrow, as attorney-in-fact
Stock symbol
PTIX
Transactions as of
May 26, 2021
Transactions value $
$0
Form type
4
Date filed
6/1/2021, 06:54 PM
Next filing
Mar 29, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTIX PTIX Common stock NSO Options Award $0 +180K $0.00 180K May 26, 2021 PTIX common stock, Par Value $0.000001 180K $3.65 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This exercise price was determined by the Board of Directors at a Board Meeting held May 26, 2021.
F2 This number of options was determined by the Board of Directors at a Board Meeting held May 26, 2021.
F3 The options are fully vested.

Remarks:

Ex. 24, Power of Attorney